Vitisin A Outperforms Cyanidin-3-O-Glucoside in Triglyceride Reduction by Modulating Hepatic Lipogenesis and Fatty Acid β-Oxidation
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26041521 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yawen Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China. Hauptthemen laut MEDLINE: Anthocyanins, Lipogenesis, Glucosides, Triglycerides. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Applied Basic Research Foundation of Guangdong Province, Department of Science and Technology of Guangdong Province.
Abstract (Originalsprache)
Pyranoanthocyanins exhibit greater bioactivity compared to monomeric anthocyanins, yet the lipid-lowering effects of pyranoanthocyanin Vitisin A, a primary derivative found in aged red wines, have not been extensively studied in vivo. This study evaluated the triglyceride-lowering effects of Vitisin A and its anthocyanin counterpart Cyanidin-3-O-glucoside (C3G) in both free fatty acid -induced HepG2 cells and high-fat diet-fed ApoE-/- mice, with a focus on their roles in lipid metabolism. In vitro, Vitisin A significantly reduced triglyceride levels and lipid accumulation in HepG2 cells compared to C3G at equivalent concentrate. In vivo, dietary supplementation with 100 mg/kg of Vitisin A reduced body weight gain and plasma triglyceride levels by 19.6% and 29.5%, respectively, whereas no significant effects were observed with C3G. Mechanistically, Vitisin A markedly inhibited hepatic de novo lipogenesis (DNL) by activating the AMPK/ACC signaling pathway and downregulating FASN expression. Concurrently, Vitisin A enhanced fatty acid β-oxidation more robustly than C3G by upregulating CPT-1A via AMPK/SIRT1/PGC-1α and PPAR-α/PGC-1α pathways. Both Vitisin A and C3G driving peroxisomal β-oxidation of very-long-chain fatty acids. In summary, Vitisin A demonstrated superior triglyceride-lowering effects compared to C3G, primarily through dual mechanisms of inhibiting hepatic DNL and enhancing fatty acid β-oxidation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Science and Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China.
ORCID-Profile: Xusheng Li
Förderung
- National Natural Science Foundation of China
- Applied Basic Research Foundation of Guangdong Province
- Department of Science and Technology of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Li, Y., Li, X., Liu, J., Jayavanth, P., Bai, W., & Jiao, R. (2025). Vitisin A Outperforms Cyanidin-3-O-Glucoside in Triglyceride Reduction by Modulating Hepatic Lipogenesis and Fatty Acid β-Oxidation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26041521
Vancouver
Li Y, Li X, Liu J, Jayavanth P, Bai W, Jiao R. Vitisin A Outperforms Cyanidin-3-O-Glucoside in Triglyceride Reduction by Modulating Hepatic Lipogenesis and Fatty Acid β-Oxidation. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26041521
BibTeX
@article{Li2025,
author = {Li, Yawen and Li, Xusheng and Liu, Jia and Jayavanth, Pallavi and Bai, Weibin and Jiao, Rui},
title = {Vitisin A Outperforms Cyanidin-3-O-Glucoside in Triglyceride Reduction by Modulating Hepatic Lipogenesis and Fatty Acid β-Oxidation},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26041521}
}
EUVIMED